BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24023496)

  • 1. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
    Cai G; Xu Y; Zhu J; Gu WL; Zhang S; Ma XJ; Cai SJ; Zhang Z
    World J Gastroenterol; 2013 Sep; 19(33):5520-7. PubMed ID: 24023496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    De Felice F; Magnante AL; Musio D; Ciolina M; De Cecco CN; Rengo M; Laghi A; Tombolini V
    Eur J Surg Oncol; 2017 Jul; 43(7):1324-1329. PubMed ID: 28363512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging.
    Kremser C; Judmaier W; Hein P; Griebel J; Lukas P; de Vries A
    Strahlenther Onkol; 2003 Sep; 179(9):641-9. PubMed ID: 14628131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
    Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR
    Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
    Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?
    Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D
    Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
    Intven M; Monninkhof EM; Reerink O; Philippens ME
    Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
    Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
    Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?
    Engin G; Sharifov R; Güral Z; Sağam EK; Sağlam S; Balik E; Asoğu O; Yamaner S; Güllüoğu M; Kapran Y; Özel S
    Diagn Interv Radiol; 2012; 18(6):574-81. PubMed ID: 22798154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.
    Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S
    Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study.
    Hein PA; Kremser C; Judmaier W; Griebel J; Pfeiffer KP; Kreczy A; Hug EB; Lukas P; DeVries AF
    Eur J Radiol; 2003 Mar; 45(3):214-22. PubMed ID: 12595106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
    Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O
    Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
    Zhao M; Zhao L; Yang H; Duan Y; Li G
    Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.